Psychiatric aspects of HIV-1 infection and AIDS by Maj, Mario
Psychological Medicine, 1990, 20, 547-563
Printed in Great Britain
Psychiatric aspects of HIV-1 infection and AIDS
MARIO MAJ*1
From the World Health Organization Division of Mental Health/Global Programme on AIDS,
Geneva, Switzerland
SYNOPSIS The literature on the psychiatric aspects of HIV-1 infection is reviewed. The whole
range of psychiatric disorders described in HIV-1 infected subjects, from HIV-1 dementia to
adjustment disorders, is covered, along with the AIDS-related psychopathology which may develop
in subjects without HIV-1 infection.
INTRODUCTION
The infection by the human immunodeficiency
virus (HIV-1) and the acquired immune de-
ficiency syndrome (AIDS) have become subjects
of considerable interest for psychiatrists and
mental health workers essentially for two
reasons: (1) the tropism of the virus for the
central nervous system, which is evident from
the fact that more than 70 % of unselected AIDS
cases present with neuropathological abnor-
malities at autopsy (Moskowitz et al. 1984;
Nielsen et al. 1984); (2) the dramatic psycho-
logical impact of the diagnosis of the infection
and of the progression of the disease on affected
individuals, which is even enhanced by their
usually young age and by their frequent be-
longing to traditionally stigmatized and
marginalized social groups. In view of this
double source of interest, it is not surprising that
two major research areas can be identified in
AIDS psychiatric literature, the former falling
on the border between psychiatry and neurology
and dealing with the clinical consequences of
HIV-1 infection of the brain, with special regard
to HIV-1 dementia, the latter falling on the
border between psychiatry and clinical psy-
chology and dealing with acute stress reactions
and adjustment disorders in subjects with HIV-
1 infection.
On the other hand, clinical experience has
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taught that dementia and acute stress reactions
or adjustment disorders are not the only psy-
chiatric conditions that may occur in HIV-1
infected subjects. In particular, two issues have
recently attracted the attention of clinicians
and research workers: (1) the possibility that
HIV-1 dementia be preceded, in the early stages
of the infection, by a subtle cognitive dys-
function, only detectable by means of specific
neuropsychological tests; (2) the possibility that
HIV-1 seropositive subjects develop acute psy-
chotic disorders, even in the absence of any sign
of cognitive impairment.
All the above research topics are briefly
covered in the present review. Furthermore,
considerable attention is paid to the AIDS-
related psychopathology (for instance, hypo-
chondriacal preoccupations or delusions) which
may develop in subjects without HIV-1 infection.
HIV-1 DEMENTIA
Aetiology and pathogenesis
HIV-1 dementia is currently believed to be
caused by the infection of the brain with HIV-1
(Navia et al. 1986a). Indeed, Southern blot
analysis has shown a high frequency and copy
number of proviral DNA in the brains of patients
with this condition (Shaw et al. 1985), in situ
hybridization has revealed the presence of viral
RNA in these brains (Koenig et al. 1986),
immunohistochemistry has detected HIV-1 anti-
gens (Gabuzda et al. 1986), electron microscopy
has identified viral particles (Epstein et al. 1985),
and HIV-1 has been directly cultured from the
brain and cerebrospinal fluid (CSF) of demented
patients (Ho et al. 1985). The cell types most
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commonly infected are macrophages and
macrophage-derived multinucleated cell. Viral
antigens have also been detected in cells identi-
fied morphologically and histochemically as
microglia (Vazeux et al. 1987), whereas it is not
clear whether other cell types, including astro-
cytes, oligodendrocytes, neurons or vascular
endothelium, may be infected. The distribution
of the infected cells seems to parallel the
neuropathological findings (see below), being
more prominent in subcortical structures
(Pumarola-Sune et al. 1987). It is unclear
whether HIV-1 enters the brain as a free virus,
or within infected monocytes and macrophages,
or through primary infection of the choroid
plexus or meningeal cells.
The pathogenesis of HIV-1 dementia remains
uncertain, although severe immunosuppression
seems to be necessary for its development. The
paucity or absence of productive infection or
lysis of neurons and glial cells suggests processes
other than simple destruction of these cells
(Price et al. 1988 a). The release of toxic
substances by infected cells has been postulated:
they may be cell-coded products or toxic
products of viral genes. Recently, an interference
of gpl20, the envelope glycoprotein of HIV-1,
with the trophic properties of neuroleukin (Lee
et al. 1987), and with the function of neuro-
transmitters such as vasoactive intestinal peptide
(VIP) (Sacerdote et al. 1987), has been
hypothesized. Moreover, an immune-mediated
destruction of myelin, similar to that produced
by Visna infection in sheep, has been invoked to
explain the rarefaction and vacuolation of the
white matter which can occur in HIV-1 dementia
(McArthur, 1987). Other recent relevant findings
include: (1) the increase of mean CSF levels of
quinolinic acid (a neurotoxic intermediate
metabolite of tryptophan) in AIDS patients, and
the significant correlation between these levels
and the stage of HIV-1 dementia (Heyes et al.
1989); (2) the decrease of the ratio between
brain concentrations of adenosintriphosphate
(ATP) and inorganic phosphate (assessed by
magnetic resonance spectroscopy) in patients
with moderate to severe HIV-1 dementia, sug-
gesting a reduction of brain energy metabolism
(Jensen et al. 1989).
Another question relevant to the pathogenesis
of HIV-1 dementia is whether there are neuro-
tropic variants of HIV-1. In fact, this virus has
a high rate of mutation, and the gene coding for
the envelope glycoprotein gpl20 appears to be
particularly variable. It has been reported that
viral CSF or brain isolates behave differently, in
lymphocyte cell cultures, from blood isolates
(Gartner et al. 1986).
Symptomatology and course
The onset of HIV-1 dementia is usually insidious.
Early symptoms can be subdivided into three
groups: cognitive, behavioural and motor
(Navia^/a/. 1986 a; Prices al. 1988 b). Cognitive
symptoms include memory and concentration
impairment and mental slowing (missing
appointments or needing lists to recall ordinary
duties; losing track of conversations or one's
own train of thought; having difficulty in
following the plot when reading or watching
TV; needing additional time and effort to
organize thoughts and to complete daily tasks).
Behavioural symptoms include apathy, reduced
spontaneity, and social withdrawal (indifference
to personal and professional responsibilities;
reduced work production; reduced frequency of
social interactions; complaints of early
fatiguability, malaise and loss of sexual drive).
Depression, irritability or emotional lability,
agitation and psychotic symptoms may more
rarely occur. Motor symptoms include loss of
balance and co-ordination, clumsiness and leg
weakness (being less precise in normal hand
activities, such as writing and eating; dropping
things more frequently than usual; tripping and
falling more frequently than usual; perceiving
the need to exercise more care in walking).
Routine mental status tests in this early stage
may be normal, or show only slowing in verbal
or motor responses and/or difficulty in recalling
a series of objects after 5 or more minutes.
Neurological examination may show tremor
(best seen when the patient sustains a posture,
such as holding the arms and fingers out-
stretched), hyper-reflexia (particularly of the
lower extremities), ataxia (usually seen only on
rapid turns or tandem gait), slowing of rapid
alternating movements (of the fingers, wrists or
feet), frontal release signs (snout reflex, palmar
grasp) or dysarthria. Tests of ocular motility
may show interruption of smooth pursuits and
slowing or inaccuracy of saccades. According to
a recent report (Currie et al. 1989), most patients
with HIV-1 dementia show, even in early stages,
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more than 25% errors when evaluated by a
bedside antisaccadic eye movement test.
In the late stages of the disease, there is usually
a global deterioration of cognitive functions and
a severe psychomotor retardation. Speech is
slow and monotonous, with word-finding diffi-
culties and possible progression to mutism.
Patients become unable to walk, due to para-
paresis, and usually lie in bed indifferent to their
illness and their surroundings. Bladder and
bowel incontinence are common. Myoclonus
and seizures may occur. Pedal paraesthesiae and
hypersensitivity may appear, due to concurrent
sensory neuropathy. The level of consciousness
is usually preserved, except for occasional
hypersomnolence.
The course of HIV-1 dementia is variable, and
no predictor of the pace of progression is
currently available. In the study by Navia et al.
(1986 a), the mean survival time once severe
dementia had been recognized was 1-8 months
(range 1-6 months) and the mean total duration
of the illness was 4-2 months (range 1-9 months),
but these estimates were probably excessively
weighted by the severity of the disease in the
author's series. In a recent study, Sidtis et al.
(1989) provided a preliminary estimate of the
rate of progression from the stage 0-5
(equivocal/subclinical) to a stage 1 or greater
(definite neurological signs and symptoms) of
HIV-1 dementia: by 37 weeks 25% of the
patients had progressed, and by 59 weeks the
progression rate was 50%. Janssen (1989)
suggested that the progression of HIV-1 de-
mentia is slower in patients with AIDS-related
complex (ARC) than in those with AIDS. Death
in patients with HIV-1 dementia usually occurs
as a result of inanition, aspiration pneumonia,
or systemic opportunistic infections.
Neuropsychological picture
Formal neuropsychological examination of
patients with HIV-1 dementia usually shows the
most prominent impairment in tests of fine
motor control (finger tapping and grooved
pegboard), rapid sequential problem solving
(trail making A and B, digit symbol), visuo-
spatial problem solving (block design), spon-
taneity (verbal fluency), and visual memory
(visual reproduction). Slowing is the major
impairment, but errors and inaccuracies are also
present. On the contrary, naming and vocabu-
lary skills are largely preserved even in the most
advanced cases. This pattern has been regarded
as consistent with the clinical and neuro-
pathological picture of a 'subcortical' dementia
(Navia et al. 1986 a; Tross et al. 1988).
Radiological EEC and laboratory findings
The predominant neuroradiological finding in
HIV-1 dementia is cerebral atrophy: both
computed tomography (CT) and magnetic res-
onance imaging (MRI) demonstrate widened
cortical sulci and, less commonly, enlarged
ventricles (Navia et al. 1986a). Furthermore,
MRI frequently shows diffuse (more rarely,
patchy or punctate) high signal intensity in the
white matter, which has been found to be
partially reversible with improved cognitive
function after treatment with azidovudine
(AZT) (Olsen et al. 1988). The assessment of the
regional cerebral metabolic rate for glucose by
positron emission tomography (PET) has been
reported to show a relative subcortical (thalamus
and basal ganglia) hypermetabolism in early
HIV-1 dementia, and cortical and subcortical
grey matter hypometabolism in the late stages of
the disease (Rottenberg et al. 1987). EEG may
be normal or, especially in late stages, show
diffuse slowing (Snider et al. 1983).
The most frequent CSF findings in HIV-1
dementia are the increase of total proteins
(typically in the order of 50 100 mg/100 ml)
and of IgG fraction and index (McArthur,
1987). Oligoclonal bands may be present. A
mild mononuclear pleocytosis may occur and
the ratio between the T-lymphocyte subsets
(CD4:CD8) may be reversed. The presence of
HIV-1, of HIV-1 specific antibodies and of the
HIV-1 antigen p24 can be detected in CSF,
although none of these findings is specific
enough to be useful for diagnostic purposes
(Paul et al. 1989). A CSF/plasma ratio higher
than I for neopterin and /?2-microglobulin has
been also reported (Goebel et al. 1989), and CSF
/?2-microglobulin levels have been found to
correlate with the stage of dementia (Brew et
al. 1989).
Neuropathology
Gross neuropathological examination of brains
from patients with HIV-1 dementia reveals
cerebral atrophy with sulcal widening and
ventricular dilatation, and occasionally men-
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ingeal fibrosis. Microscopic abnormalities are
most prominent in central white matter and
deep grey structures, with relative sparing of the
cortex (Navia et al. 1986ft). The most common
feature is pallor of the central and periventricular
white matter. Rarefaction and, in more severe
cases, diffuse or focal microvacuolation of
white matter may be detected. Multinucleated
cells are seen in the most severe cases: they
appear to result from virus-induced cell fusion,
and tend to cluster around the microvasculature.
Other features include perivascular infiltrates
(consisting of macrophages, lymphocytes and
microglia along with multinucleated cells) and
diffuse astrocytosis.
Epidemiology
The estimate of the prevalence of HIV-1 de-
mentia is largely influenced by the source from
which patients are recruited, the stage of
infection and the criteria used for the diagnosis.
In a recent paper by Janssen et al. (1989 a), all
cases of AIDS reported to the Centres for
Disease Control (CDC) of Atlanta (USA) from
1 September 1987 to 31 December 1988 were
considered. A case of HIV-1 dementia was
defined as a person who was HIV-1 seropositive
and presented with disabling cognitive and/or
motor dysfunction in the absence of a condition
other than HIV-1 infection that could explain
the findings. Of the adults 6-5% had HIV-1
dementia and 3-0 % were reported to have it as
the only early manifestation of AIDS. Previous
estimates of the point prevalence of HIV-1
dementia in AIDS patients ranged from 8-16%,
whereas the estimates of the percentage of AIDS
patients in whom HIV-1 dementia is the pre-
senting manifestation ranged from 0-3-3%
(WHO, 1988). As expected, the prevalence of
HIV-1 dementia is found to be much higher in
autopsy series of cases reported to neurologists,
reaching the figure of 66% (Price et al. 1988 a).
Differential diagnosis
In patients with recognized systemic AIDS, the
differential diagnosis involves opportunistic
infections and neoplasms or metabolic
encephalopathies that may cause diffuse cerebral
dysfunction. Among opportunistic infections,
cryptococcal meningitis, cytomegalovirus en-
cephalitis, herpes simplex encephalitis and cer-
ebral toxoplasmosis are particularly important,
whereas, among opportunistic neoplasms, pri-
mary CNS lymphoma should be considered.
These conditions, as well as the metabolic
encephalopathies, can often be distinguished
from HIV-1 dementia by their more abrupt
onset and rapid evolution, and by the parallel
impairment of cognition and consciousness.
Moreover, CT and MRI can be useful in
demonstrating the cerebral atrophy and white
matter abnormalities that are characteristic of
HIV-1 dementia, and CSF examination can be
decisive especially in ruling out cryptococcal
meningitis. However, it is important to stress
that the above disorders may coexist with HIV-
1 dementia in AIDS patients (Price et al. 1988 ft).
In patients without recognized AIDS, the
differential diagnosis is more difficult, involving
multiple sclerosis, Parkinson's disease,
Alzheimer's disease, and mood or psychotic
disorders. Therefore, in the presence of a clinical
picture resembling that described above, a search
for risk factors for AIDS should be pursued,
and, if present, HIV-1 serological testing should
be always considered (Price et al. 1988 ft).
Treatment
A beneficial effect of the antiviral agent azido-
vudine (AZT) on several cognitive measures in
patients with HIV-1 dementia has been
demonstrated in one open (Yarchoan et al.
1987) and one double-blind placebo-controlled
trial (Schmitt et al. 1988), but not confirmed in
another placebo-controlled investigation (Grant
et al. 1987 a). One of the main disadvantages of
this drug is bone marrow suppression. Further
studies are clearly required to establish the
impact of such treatment, especially in the long-
term. At present, therapy of HIV-1 dementia is
essentially limited to the management of
symptoms and the provision of psychosocial
support to the patients and their carers. The use
of tricyclic antidepressants should be avoided,
because they may provoke or exaggerate
delirium. In individuals with marked apathy and
psychomotor retardation, a short trial with
psychostimulants may be useful.
The care of patients with HIV-1 dementia will
make increasing demands on health services, as
well as on volunteer and community support
systems. It is uncertain, at present, whether such
care is best provided in specialized units (e.g. in-
patient AIDS units), or within general psy-
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chiatric or medical services. Special management
problems may arise when the behavioural
disturbance (e.g. poor impulse control, sexual
acting-out behaviour or biting) is such as to
constitute a risk for other patients or staff
members (Raphael et al. 1989). Placement of
patients in the terminal stage of the disease may
also represent a problem: the lack of appropriate
options in the community may obstruct their





The presence of neuropsychological abnormali-
ties in a substantial proportion of symptomatic
HIV-1 seropositive subjects, not showing the
clinical picture of HIV-1 dementia, has been
repeatedly reported, whereas the occurrence of
such abnormalities in HIV-1 seropositive other-
wise asymptomatic individuals is currently
debated.
Tross et al. (1988) applied a battery of
neuropsychological tests in four groups of
subjects: 44 newly diagnosed AIDS patients, 40
AIDS patients referred for neurological con-
sultation, 16 asymptomatic HIV-1 seropositives,
and 20 HIV-1 seronegative controls. The two
AIDS groups showed a worse performance than
both non-AIDS groups in tests of visuo-spatial
ability (block design), sequential problem solving
(trail making A and B, digit symbol) and fine
motor control (grooved pegboard), and the late
AIDS group was also distinguishable from the
other groups on a test of motor speed (finger
tapping). No significant difference was observed
between asymptomatic HIV-1 seropositives and
HIV-1 seronegative controls. When the subjects
were subdivided into those with severe im-
pairment (four or more abnormal test scores),
mild impairment (two or three abnormal test
scores) and low impairment (no or one abnormal
test score), no HIV-1 seronegative individual
showed either mild or severe impairment,
whereas one asymptomatic HIV-1 seropositive
showed mild and one severe impairment.
Somewhat different results have been obtained
by Grant et al. (19876), who studied 15 patients
with AIDS, 13 patients with AIDS-related
complex (ARC), 16 asymptomatic HIV-1 sero-
positives and 11 HIV-1 seronegative controls.
AIDS patients performed significantly worse
than the other three groups on a neuro-
psychological measure of attention and speed of
information processing, and significantly worse
than HIV-1 seronegatives on a measure of non-
verbal abstracting ability. No significant differ-
ence was observed between asymptomatic HIV-
1 seropositives and HIV-1 seronegatives. Never-
theless, when the performance of each subject
was classified as abnormal (i.e. definitely im-
paired on at least one test or probably impaired
on at least two tests), the percentage of ab-
normality was 87% in AIDS patients, 54% in
patients with ARC, 44% in asymptomatic
HIV-1 seropositives and 9% in HIV-1 sero-
negatives.
More recently, Janssen et al. (1989 b) evaluated
26 patients with ARC, 31 patients with
generalized lymphadenopathy, 43 asymptomatic
HIV-1 seropositives and 157 HIV-1 sero-
negatives. The ARC group was the only one to
show significant differences with respect to the
HIV-1 seronegative group (worse performance
on tests of memory and perceptual speed).
Defining abnormality as a performance worse
than the cut-off score (1 or 1-5 S.D. of the mean
of the control group) on tests of two or more
functional domains (among the following:
memory, perceptual speed, scanning, motor,
language), significantly more ARC patients than
HIV-1 seronegatives had an abnormal neuro-
psychological performance, whereas neither
patients with generalized lymphadenopathy nor
HIV-1 seropositive asymptomatics differed
significantly from HIV-1 seronegatives. Using
the cut-off point of 1-5, the percentage of
asymptomatic HIV-1 seropositives with an ab-
normal performance was 14%, and that of HIV-
1 seronegatives 12%.
Consistent with these last data are the pre-
liminary results of the large Multicentre AIDS
Cohort Study (MACS). Seines et al. (1989)
reported that, by using a comprehensive neuro-
psychological battery, no significant difference
on any measure was observed between 225
asymptomatic HIV-1 seropositives and 181
HIV-1 seronegatives. Less than 10% of sero-
positives had abnormal performances (cut-off
score 2 s.D. of the mean of the seronegative
group) on individual subtests, which did not
differ significantly from HIV-1 seronegatives.
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No significant difference in the performance
on neuropsychological tests between HIV-1
seropositive asymptomatic subjects and HIV-1
seronegative controls has been also found by
Goethe et al. (1989), whereas Perry et al. (1989)
reported that the number of HIV-1 seropositive
asymptomatic subjects with one or more neuro-
psychological test scores below the sample mean
was significantly higher than that of HIV-1
seronegative controls.
Methodological issues
Comparability of the results of the studies in this
area is hampered by several factors: differences
in the domains assessed by the various authors
and in the instruments used to assess similar
domains; dissimilarity of the populations and of
the sample sizes; different approaches used in
the analysis of data and in the definition of
thresholds for abnormality; different attention
to cofactors (such as psychiatric symptoma-
tology, substance abuse, prescribed medication,
history of childhood learning difficulties or CNS
traumas). Moreover, the group of asymptomatic
HIV-1 seropositives is likely to be heterogeneous
from the immunological viewpoint, and subjects
with immunological decline may have a worse
cognitive performance (Goethe et al. 1989),
which may explain in part the disagreement
existing in the literature. In any case, the
relationship between neuropsychological im-
pairment in early stages of HIV-1 infection and
the subsequent development of HIV-1 dementia
remains to be established by means of longi-
tudinal studies.
DELIRIUM
Delirium has been described within the context
of HIV-1 dementia (Price et al. 1988 a) and of
the aseptic meningitis which may develop upon
seroconversion (McArthur, 1987). Moreover, its
occurrence in AIDS patients may be related to
hypoxia (for instance, from Pneumocystis carinii
pneumonia), cryptococcal meningitis, systemic
infections (such as staphylococcal bacteraemia),
space occupying lesions of the brain (such as
CNS lymphoma or brain abscesses due to
toxoplasmosis), metabolic derangements (dis-
orders of fluid, electrolyte or acid-base balance),
and the use of psychotropic drugs (especially
tricyclic antidepressants, whose central anti-
cholinergic activity seems to be more pro-
nounced in such patients).
The clinical picture of delirium is characterized
by clouding of consciousness with reduced
capacity to shift, focus and sustain attention to
environmental stimuli; perceptual disturbances
(misinterpretations, illusions and hallucina-
tions); disorientation and memory impairment;
incoherent speech; insomnia; increased (more
rarely decreased) psychomotor activity. The
syndrome usually develops over a short period
of time (hours to days) and its intensity tends to
fluctuate during the course of a day. Complete
recovery is the rule in delirium occurring at the
time of seroconversion. Delirium superimposed
on HIV-1 dementia may aggravate its course
(Price et al. 1988 a).
There is no available estimate of the preva-
lence and incidence of delirium in HIV-1
infection. Management of the syndrome consists
in treating the underlying cause, maintaining
fluid and electrolyte balance and nutrition,
providing sedation, correcting disturbances of
sleep-wake cycle, supplying a quiet environment




Acute stress reactions may occur in any phase of
HIV-1 infection, especially in coincidence with
changes in the individual's clinical state. How-
ever, they are most common immediately after
the diagnosis of the infection.
Psychological reactions to the diagnosis of
HIV-1 infection resemble those commonly de-
scribed in response to the diagnosis of cancer or
other life-threatening diseases. They also reflect,
however, the specific psychosocial dimensions
relevant to AIDS, such as the stigma associated
with homosexuality and drug abuse, and the
society's fear of contagion. In practice, subjects
receiving the diagnosis are suddenly confronted
not only with the likelihood of developing a
disease with a very poor prognosis and for
which no effective therapy is available, but also
with several other issues: revealing their homo-
sexuality or drug abuse to family, friends and
colleagues; dealing with the fears of partner,
family, friends and public; avoiding transmitting
the infection to others and protecting themselves
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from opportunistic infections (Christ et al. 1988;
Miller, 1988). The age at which the diagnosis is
usually made has been regarded as another
traumatic factor: most subjects are 25- to 49-
years-old, an age group that does not expect to
develop a potentially fatal illness (Christ et al.
1988). For all the above reasons, it is not
surprising that acute stress reactions have been
reported in up to 90 % of subjects with a recent
diagnosis of HIV-1 infection (WHO, 1988).
The occurrence of acute stress reactions has
been found to be particularly frequent in subjects
lacking a partner or living in a rural environ-
ment, and, according to a report from Germany
(Seidl & Goebel, 1987), to be more common in
homosexuals than in drug abusers. On the other
hand, no increased overall levels of distress have
been reported in a population where most
individuals had correctly predicted their test
results (Stempel et al. 1987), and it has been
maintained that for some patients who had been
chronically ill, but not easily classifiable or
manageable, the news of the diagnosis may even
be greeted with a sense of relief, because they
have at last something concrete to fight, and
can be enrolled in promising experimental
treatment programmes (Miller & Green, 1986).
Clinical manifestations
A state of shock, in which the subject feels
confused and bewildered, with the mind in
constant turmoil, and in which depersonaliz-
ation, derealization and sleep disorders may
occur, has been found to be frequently the initial
reaction to the diagnosis (Deuchar, 1984). Other
emotional and behavioural reactions may in-
clude anger (at being 'caught out', over inability
to change circumstances, over lacking or con-
fusing information from staff), which may be
expressed by abusive language or even physical
aggression, and be directed towards society, old
or contemporary sexual partners, family or
health care givers; withdrawal (distancing from
the present issues and circumstances, losing
interest in human contact, 'hiding beneath the
bedsheets'); guilt (the search for a reason for
being 'singled out' leads to the belief that the
illness is a retribution for homosexuality or drug
abuse); denial (an attitude of indifference, which
may lead to a dangerous disregard for medical
advice); fear (of death or disfigurement; of
losing cognitive or physical abilities; of isolation,
abandonment, social or sexual rejection; of
infecting others; of family's or partner's inability
to cope); despair (Morin et al. 1984; Dilley et al.
1985; Miller, 1987). These reactions may involve
the appearance of somatic symptoms, that can
be interpreted by the subject as evidence of a
physical decline (Nichols, 1985). Bodily checking
for signs of progression of the infection has been
also described (Holland & Tross, 1985). Finally,
the diagnosis may be followed by suicidal
ideation or attempts, substance abuse, or high-
risk activities (Holland & Tross, 1985; Muluka,
1988; Rundell et al. 1988). In the absence of
adequate management, acute stress reactions
may last several weeks or longer (WHO, 1988).
Management
The management of psychological reactions to
the diagnosis of HIV-1 infection is based on pre-
and post-test counselling. Pre-test counselling
involves: (1) helping the subject to analyse the
reasons for wanting the test and to evaluate the
likelihood that he/she is infected; (2) explaining
that the test is not expected to provide a diagnosis
of AIDS or any information concerning severity
of the infection, infectiousness or prognosis; (3)
explaining that false positive or negative results
may occur; (4) informing the subject of the
potential consequences of identified sero-
positivity (psychological reactions, interpersonal
problems, social discrimination, possible diffi-
culties in obtaining dental or medical treatment);
(5) informing the subject about how the infection
is transmitted and how transmission can be
prevented; (6) explaining the relative protections
offered by confidential testing (Goldblum &
Seymour, 1987; Miller, 1987; Christ cr al. 1988).
After pre-test counselling, the subject should be
ideally given some days to take the final decision
whether to undergo the test or not. If he/she
decides to proceed, an appointment for blood
sampling should be made. Post-test counselling
in seropositives involves: (1) presenting the
results in a sensitive but honest manner, since
any incomplete information may result in a loss
of confidence in medical staff and in a reduced
motivation to comply with prescribed be-
havioural changes; (2) informing the subject
about HIV-1 infection and AIDS, avoiding any
unwarranted estimate of the time left to live or
definitive prognosis; (3) prompting the subject
to talk about his/her concerns, worries and
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fears; (4) reinforcing the subject's will to fight
the infection and to look for a good quality of
life; (5) providing human contact and touch; (6)
informing the subject of the resources available
in the community (self-help groups, AIDS
information services), and providing the tele-
phone numbers of the clinic or community
counsellors; (7) cautioning the subject against
the natural impulse to reveal his/her situation to
friends or colleagues, since their reactions cannot
be predicted and may have adverse conse-
quences; (8) providing detailed guidelines about
safer sex and other precautions aimed to control
the infection and avoid its spreading (Miller &
Green, 1986; Christ et al. 1988). Since the above
described psychological reactions to the di-
agnosis may preclude comprehension and
change the way in which the subject reacts to
others, one counselling session after the test is
rarely sufficient. A follow-up within some days
should be usually planned, and at that stage the
involvement of the partner is desirable.
ADJUSTMENT DISORDERS
Psychological background
A morbid (that is, excessive in length and/or
intensity) response to the diagnosis of HIV-1
infection or AIDS, or more generally to the
stress associated with the disease, can be
conditioned by several factors. Subject's coping
strategies are certainly involved: Namir et al.
(1987) have shown that the style of coping
adopted by subjects with a recent diagnosis of
AIDS was predictive of their psychological well-
being, with the highest levels of depression
found in those who relied upon avoidance of the
reality of the diagnosis, and the highest fre-
quency of obsessive thoughts in those adopting
an active-cognitive coping style (involving 'the
building of mental defences and the development
of a sense of meaning about their illness').
Reservations about homosexuality or lifestyle
also seem to be important: in subjects who have
internalized social non-acceptance of homo-
sexuality or drug abuse, the diagnosis of HIV-1
infection may be taken as an evidence of past
'wrong doing', thus generating feelings of guilt
and self-depreciation (Hays & Lyles, 1986;
Miller, 1988). Previous history of psychiatric
disorders has been also regarded as a vul-
nerability factor (Holland & Tross, 1985).
Family, occupational and social acceptance is of
critical importance: subject's emotional distress
can be enhanced by familial estrangement or by
the development within the family of a con-
spiracy of avoidance, because of which the
diagnosis is never discussed (Miller, 1988); by
over-concern over the impact of diagnosis on
the loved-ones; by loss of job or career resulting
from the employer's knowledge of the illness; by
coexisting financial difficulties. The importance
of social support has been recently documented
by Zich and Temoshok (1987), who showed
that, in patients with ARC or AIDS, the more
social support was perceived to be available, the
less hopelessness and depression were reported.
In this study, emotionally-sustaining social
support was rated by the patients to be more
desirable than practical support (particularly
when coming from lovers, friends or families).
Moreover, the possibility was considered that
the sickest patients may receive less social
support because they are not able to take it up (a
finding which is consistent with the observation
by Namir et al. (1987) that patients relying on
avoidance as a coping style receive less support
since they are seen as less motivated and
attractive by support givers). Finally, adjustment
disorders have been found to be more frequent
in subjects with ARC than in those with AIDS
(Temoshok et al. 1986; Tross et al. 1986), which
finding has been ascribed to the greater level of
uncertainty about the future in subjects with
mid-stage manifestations of the disease.
Clinical manifestations and prevalence
The clinical picture of adjustment disorders in
subjects with HIV-1 infection or AIDS may be
dominated by depression, anxiety, or obsessions
and compulsions.
Depression is commonly related by patients
to the lack of any effective cure for AIDS; to the
apparent inevitability of physical and cognitive
decline and future disability; to the present or
anticipated social, occupational and sexual
rejection; to the restrictions that the illness
places on the activities that previously gave a
meaning to life (sex, work, travelling, etc.)
(Miller, 1987). Depressive symptoms include
sadness; feelings of guilt (the patient feels that
he/she deserves the illness, and that the current
situation is evidence of his/her past misdeeds),
worthlessness and helplessness; suicidal
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thoughts (not only based on a desire of self-
destruction, but also on the wish not to be
anymore a burden on the loved ones); loss of
interest and pleasure in usually enjoyed ac-
tivities; difficulties with memory and concen-
tration (which may create diagnostic problems
with respect to HIV-1 dementia); loss of energy
(which may be difficult to distinguish from
fatigue occurring as a physical symptom of
ARC), appetite and sexual drive; social with-
drawal; sleep disturbances. To what extent
depression may impair cellular immunity, thus
speeding the progression of HIV-1 infection,
remains uncertain.
Anxiety is commonly related by patients to
the following issues: the outcome of the infection
in the long term, future isolation and aban-
donment, future loss of physical and financial
independence, the risk to infect others or to be
infected by them, being identified as a homo-
sexual or a drug abuser, inability by the partner
or the family to cope with the situation, possible
difficulty in obtaining medical treatment (Miller,
1987). The usual psychic and somatic symptoms
of anxiety may all be present. Some of the
somatic symptoms (such as diarrhoea, nausea,
sweating, fatigue, skin rashes) are similar to
those of ARC, so that they may be regarded by
the patient as an evidence of the progression of
the infection. This produces a further increase of
anxiety and possibly a worsening of the somatic
symptoms themselves, which confirms the
patient's worries.
Obsessive/compulsive symptoms may include
mental checking (going over and over past
sexual experiences, trying to find out whether
past partners showed any sign of illness; going
over and over recent activities, trying to identify
any event that may have exposed family or
friends to the infection); bodily checking or
palpating specific bodily areas in order to
discover the signs of the illness; obsessional
thoughts or mental pictures of physical decline
or death.
Adjustment disorders may last many months
(WHO, 1988). They have been reported to
represent the most frequent diagnosis in patients
with ARC or AIDS referred for psychiatric
consultation (Dilley et al. 1985; Tross et al.
1986; Rundell et al. 1988; Schaerf et al. 1989).
The frequency of these disorders in 85 con-
secutive consultations from an in-patient AIDS
unit has been found to be significantly higher
than in 85 consecutive consultations from a
general hospital (Schaerf et al. 1989).
Management
Management of adjustment disorders has been
found to benefit from behavioural and cognitive
psychotherapy on an individual or group basis,
encouraging positive involvement in activities,
expression of thoughts and feelings,
information-seeking, problem-solving and
decision-making, and emphasizing patient's
self-worth. Such an approach should involve
partners or family members as the patients judge
appropriate (Miller, 1989).
Pharmacological treatment of depression and
anxiety may be useful. Nevertheless, patients
with ARC and AIDS appear to be particularly
sensitive to the side-effects of antidepressant
drugs, so that low starting doses and small
increments should be the rule. It would be
desirable to choose drugs with minimal anti-
cholinergic effects, in order to avoid the risk of
delirium and extra drying of mucous membranes.
Caution is warranted also in the use of benzo-
diazepines, due to the high liability to drug
abuse of some subjects with HIV-1 infection,
and the risk of impaired respiratory functioning
in patients with Pneumocystis carinii pneumonia
(one of the most frequent opportunistic infec-
tions occurring in AIDS).
ACUTE PSYCHOTIC DISORDERS
Psychotic syndromes with evidence of cognitive
impairment
Hallucinations (either visual or auditory) and
delusions (either persecutory or grandiose) are
not infrequent in patients with ARC or AIDS.
They may occur within a context of cognitive
impairment, which may be sometimes subtle
or fluctuating (Kermani et al. 1984; Nurnberg et
al. 1984; Koppel et al. 1985; Perry & Jacobsen,
1986; Rundell et al. 1986; Beckett et al. 1987;
Maccario & Scharre, 1987; Thomas & Szabadi,
1987), or they may be initially the only psycho-
pathological manifestations, being followed later
by such symptoms as disorientation, clouding of
consciousness, memory and concentration dis-
turbances (Hoffman, 1984; Navia et al. 1986a).
In both these cases, a diagnosis of organic brain
syndrome (dementia or delirium) is usually
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warranted. Indeed, many cerebral diseases may
present in their early stages with a clinical
picture which is indistinguishable from that of a
functional psychosis: syphilis is a widely quoted
example (Lishman, 1987).
Psychotic syndromes without evidence of
cognitive impairment
There are, however, also reports of patients with
otherwise asymptomatic HIV-1 infection, ARC
or AIDS who developed acute psychotic dis-
orders without any evidence of cognitive im-
pairment throughout the episode. Thomas et al.
(1985) described an HIV-1 seropositive homo-
sexual man who presented with lymph-
adenopathy and a psychotic syndrome,
characterized by persecutory and grandiose
delusions and bizarre behaviour, which re-
sponded to trifluoperazine. Halevie-Goldman et
al. (1987) reported on an HIV-1 seropositive
homosexual man presenting with persecutory
delusions and auditory hallucinations in the
absence of somatic symptoms (outcome not
specified). Buhrich et al. (1988) described two
subjects with ARC, of whom one presented
with blunted affect, multiple delusions and
formal thought disorder, and the other with
bizarre delusions and behaviour, incongruity of
affect and formal thought disorder, both re-
covering after fluphenazine treatment. Halstead
et al. (1988) reported on four cases of HIV-1
infection associated with lability of mood (with-
out a dominant shift towards depression or
mania), a variety of delusional beliefs, formal
thought disorder and (in three cases) auditory
hallucinations of these persons, three improved
on neuroleptics and one committed suicide.
The occurrence of acute psychotic disorders
without evidence of cognitive impairment in
subjects with HIV-1 infection may be interpreted
in many ways (Buhrich et al. 1988; Vogel-
Scibilia et al. 1988): (1) they may be one of the
possible reactions to the diagnosis of HIV-1
infection or AIDS (this was indeed the case in a
patient described by Rundell et al. (1986), who
became agitated and deluded when told he was
seropositive, and rapidly recovered when the
results of a repeat test were reported to him as
negative); (2) they may be induced by drugs
used or abused by the patient (this was the case
in a patient described by Campbell (1987), who
developed an acute paranoid disorder following
a treatment with high-dose methylprednisolone
for Pneumocystis carinii pneumonia); (3) they
may result from the chance association of
psychosis and HIV-1 seropositivity (on the basis
of currently available data, this association can
be expected to occur by chance in 750 new cases
every year within the population of the United
States, or even more frequently if one considers
that subjects at high-risk for HIV-1 infection
and individuals with a first psychotic episode
share many features); (4) they may be pre-
cipitated by HIV-1 infection in predisposed
subjects; (5) they may be directly related to
HIV-1 infection of the brain. The third and the
fifth hypotheses have been regarded as the most
plausible in the cases in which knowledge of
HIV-1 seropositivity by the subject, drug effects
and a personal or family history of psychosis
can be excluded (Halstead et al. 1988). A specific
vulnerability of dopaminergic systems in AIDS
has been suggested by Hollander et al. (1985),
and regarded by Maccario & Scharre (1987) as a
possible pathogenic mechanism responsible
for schizophreniform psychoses in HIV-1 in-
fected subjects. The predilection of HIV-1 for
the limbic system has been also discussed in
connection with a case of catatonia in an HIV-
1 seropositive subject, in whom PET scan
showed increased blood flow and glucose
metabolism in the right temporal cortex and
basal ganglia (Volkow et al. 1987).
Epidemiology and treatment
The incidence and prevalence of either psychotic
symptoms or syndromes in subjects with HIV-1
infection, as compared with the general popu-
lation, is completely unknown. The response of
these syndromes and symptoms to neuroleptics
has been found to be frequently favourable
(Vogel-Scibilia et al. 1988). Nevertheless, AIDS
patients have been regarded as susceptible
to extrapyramidal side-effects of antipsychotic
drugs: the patient described by Maccario &
Scharre (1987) developed parkinsonism after 3
weeks of treatment with haloperidol 2 mg/day,
whereas Edelstein & Knight (1987) reported
severe extrapyramidal side effects (including
dystonia, rigidity, drooling and akathisia) in two
cases treated with the low-potency phenothiazine
prochlorperazine (10 mg every 6 h).
The management of HIV-1 infected patients
with acute psychotic disorders may involve
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special practical and ethical dilemmas. If the
subject displays out-of-control behaviour which
is likely to transmit the virus, and there is a
significant risk that such behaviour cannot be
controlled by other measures, the question may
arise whether the patient's infectious condition
can be disclosed to other patients at risk. The
position taken by an ad hoc committee of the
American Psychiatric Association (1988) is that
in these conditions disclosure is permissible. The
same committee also concluded that when
discharge is otherwise clinically appropriate, if
the patient represents a substantial risk to others
by virtue of a behaviour known to transmit the
virus, but this danger is not related to a specific
mental condition, it is inappropriate to retain




A depressive syndrome not fulfilling ICD-10
criteria for severe depressive episode or DSM-
IIIR criteria for major depression may occur at
any point in the course of HIV-1 infection, but
more frequently in the period following the
identification of HIV-1 seropositivity (adjust-
ment disorder with depressed mood) or in the
initial stage of HIV-1 dementia (WHO, 1988).
Moreover, depressive symptoms may result from
the occurrence of opportunistic infections or
neoplasms (Perry & Tross, 1984), or from the
use of antineoplastic drugs for Kaposi's sarcoma
or malignant lymphomas (Chabner & Myers,
1985; Volberding et al. 1985). It is important to
emphasize that depressive symptoms may be
difficult to differentiate from some manifest-
ations of ARC (fatigue, anorexia, weight loss,
loss of libido, sleep disorders) or of dementia
(slowness of mental processes, memory and
concentration disturbances).
Major depression has been reported in sub-
jects with HIV-1 infection, but estimates con-
cerning its prevalence have been quite divergent.
Perry & Tross (1984) retrospectively reviewed
the charts of 52 AIDS patients admitted to the
New York Hospital: mood disturbance was
identified in 82-7 % of them, and a DSM-III
diagnosis of major depression was made in
17-3 %. Rundell et al. (1988) reviewed the records
of 111 HIV-1 seropositive subjects seen by the
psychiatric consultation service at the Medical
Center for US Air Force in Texas: a diagnosis of
major depression according to DSM-IIIR was
made in 3-6% of subjects. Schaerf et al. (1989),
in their already mentioned comparison between
85 consecutive psychiatric consultations from
the in-patient AIDS unit of the Johns Hopkins
Hospital and 85 consecutive psychiatric general
hospital consultations, found that in the former
group a diagnosis of major depression was made
in 7% of cases, that is, significantly less
frequently than in the latter group. These
discrepancies probably reflect the small size of
the subject samples and the different sources
from which they were recruited. It is also
important to stress that the vulnerability to
depression may be different in the various groups
at risk for HIV-1 infection.
Major depression in HIV-1 infected subjects
may be interpreted in several ways: (1) it may
result from the above mentioned psychosocial
problems related to HIV-1 infection and AIDS;
(2) it may be directly related to HIV-1 infection
of the brain (in view of the predilection of HIV-
1 for limbic areas, which are believed to control
emotional experience); (3) it may be precipitated
by HIV-1 infection in a predisposed subject; (4)
it may result from the chance association of
affective illness and HIV-1 seropositivity.
Manic syndromes
A few cases of hypomania or mania in subjects
with HIV-1 infection have been also described.
In some of them, cognitive impairment was
associated or soon developed, thus suggesting a
diagnosis of organic brain syndrome (Kermani
et al. 1985; Gabel et al. 1986; Perry & Jacobsen,
1986; Dauncey, 1988; Schmidt & Miller, 1988);
in some others, cognitive impairment did not
appear throughout the episode (Buhrich et al.
1988; Schmidt & Miller, 1988). The possible
interpretations of these last cases are similar to
those proposed for acute psychotic disorders.
Treatment
Major depression and mania occurring in sub-
jects with HIV-1 infection have been reported to
be usually responsive to the standard treatment
with antidepressants or neuroleptics. The pre-
viously mentioned susceptibility of HIV-1
infected patients to the side-effects of these drugs
should be, however, considered. Indeed, in the
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manic patient described by Gabel et al. (1986), a
reaction including diaphoresis, rigidity and
pyrexia ensued following treatment with oral
trifluoperazine and lithium carbonate, which
was interpreted as a neuroleptic malignant
syndrome.
SUICIDE
HIV-1 infection and AIDS have been found to
be associated with a high risk of suicide. Marzuk
et al. (1988), in a study of the suicide rate in New
York City in 1985, reported that the relative
risk of suicide in men with AIDS aged 20-59
years was 36-3 times that of men in the same age
range without this diagnosis, and 66-15 times
that of the general population. All suicides of
AIDS patients had occurred within 9 months
after receiving the diagnosis, most of them within
6 months. Three suicides (25 %) had occurred in
the medical units of general hospitals (all by
jumping from windows). Five of the 12 subjects
had seen a psychiatrist within 4 days before
suicide (two of them had been treated for
depression in a psychiatric hospital within one
month before the suicide). Five subjects had
expressed suicidal intentions to family, friends,
physician or police in the days before their
suicide; four subjects had each made one
previous suicide attempt (in two cases, the
attempt had been made soon after the diagnosis
of AIDS). Ten of the 12 subjects were unmarried;
nine of them were homosexuals or bisexual. The
authors emphasized that the suicide rate re-
ported in the study may be underestimated,
since there may have been suicide victims in
whom the diagnosis of AIDS was not reported
or even not suspected, as well as AIDS patients
in whom suicide was not recognized as the cause
of death. They listed a number of psychosocial
factors which may precipitate suicide in AIDS
patients, including the social stigma related to
the illness, the withdrawal of family support,
diminished or lost occupational functioning,
long-term dependency, loss of friends or lovers
(often due to AIDS), and the spectre of an
inexorable terminal illness that may lead to pain,
disfigurement and emaciation. They also pointed
out that the presence of concomitant psychiatric
syndromes, especially depression and delirium,
may increase the rate of suicide in AIDS patients.
The high risk of suicide in HIV-1 infection has
been confirmed by Rundell et al. (1988), who
found that in 147 HIV-1 seropositive subjects,
followed up for an average of 108 months by
the psychiatric consultation service at the Medi-
cal Center for US Air Force in Texas, there were
seven suicide attempts and one successful suicide
(attempt rate of 4500/100 000/year). A retro-
spective analysis revealed the following factors
predictive of a suicide attempt: multiple psycho-
social stresses, perceived social isolation, per-
ceiving oneself as a victim, reliance on denial as
the central or only defence, substance abuse and
perceived unavailable social support. Other
possible risk factors were disease progression,
abnormal CSF, past history of psychiatric illness
and personality disorder.
The high risk of suicide in the period following
the diagnosis of HIV-1 infection has been
confirmed by Miller (1989), who stressed that
the likelihood of impulsive suicidal activity is
influenced by the manner in which news of the
infection is presented, by the availability of
social, emotional and practical support, and by
the provision of adequate pre- and post-test
counselling.
Finally, both Marzuk et al. (1988) and Miller
(1989) have mentioned that in some AIDS
patients refusal of treatment or reckless activities
may represent suicidal equivalents.
AIDS-RELATED PSYCHOPATHOLOGY
IN SUBJECTS WITHOUT HIV-1
INFECTION
Hypochondriacal syndrome (the 'worried well')
A hypochondriacal syndrome, marked by the
persistent belief in the presence of HIV-1
infection, despite repeated negative serological
tests and clinical examinations, has been de-
scribed by several authors (Forstein, 1984;
Miller, 1986; Hutner &Zemann, 1988; Miller el
al. 1988). It has been pointed out (Miller et al.
1988) that subjects presenting with this syndrome
(the 'worried well') should be distinguished
from those who become anxious as a result of
media coverage of AIDS and therefore require
HIV-1 serology, but who experience long-term
reassurance following negative laboratory and
clinical findings.
The clinical features of the 'worried well'
include anxiety, with the possible occurrence of
panic attacks (triggered by media coverage of
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AIDS or social discussion of the topic); anxiety-
based physical symptoms and signs (fatigue,
sweating, skin rashes, muscle pains, diarrhoea,
palpable lymph nodes), which are misinterpreted
as manifestations of HIV-1 infection; obsessive
thoughts (ruminations over past high-risk sexual
practices, threats of infection to the loved ones,
dirtiness or infectivity of bodily fluids); com-
pulsive behaviour (palpating specific bodily
areas or checking for Kaposi's sarcoma lesions,
washing sources of potential contamination);
depression with possible suicidal behaviour
and/or substance abuse. A high rate of recent
attendance of medical services is the rule (Jager-
Collet, 1988; Miller, 1988).
The 'worried well' usually give very detailed
and dramatic descriptions of their bodily symp-
toms. They frequently ascribe the negativity of
their laboratory tests to the fact that the current
methods cannot offer a 100% assurance, or that
they are among the few persons who cannot
form antibodies against HIV-1, or that they
have been infected by a mutated or new virus
which cannot be identified by currently available
tests (Hutner & Zemann, 1988). Very often, the
basis given for the supposed HIV-1 infection is
a sexual contact, mostly with a person who is
not the steady partner (Hualla & Jaeger, 1988).
A severe social disability, with avoidance of
possible sexual partners and abandonment of
professional activities, may occur in some cases.
Difficulties in sexual adjustment have been
almost consistently observed in the 'worried
well'. Indeed, it has been maintained that in
some of these individuals the public anxiety
about AIDS appears to act as a vehicle for the
expression of sexual guilt or anxiety (Miller et al.
1988). Hutner & Zemann (1988) have reported
that, with few exceptions, the 'worried well' do
not belong to the principal groups at risk for
HIV-1 infection, but Miller et al. (1988) have
found that 11 of their 19 patients were homo-
sexual or bisexual, although almost all of them
had a recent history of low-risk sexual activity.
A past history of psychiatric disorders (mostly
depression and anxiety) has been found to be
frequent.
The differential diagnosis of HIV-1 related
hypochondriacal syndrome may be difficult. In
particular, the possibility that a psychosis is
concealed behind the hypochondriacal com-
plaints should be considered (Naber & Hippius,
1988). The way in which the belief of infection
is presented may be important: a bizarre,
delusional pattern can be the first indication of
the presence of a psychosis.
The management of the' worried well' appears
to benefit from a cognitive-behavioural
approach, involving: (1) the re-interpretation of
symptoms in terms of anxiety rather than
manifestations of HIV-1 infection; (2) the
institution of a stress inoculation training (Hedge
etal. 1988; Miller et al. 1988).
Other AIDS-related psychopathology
Other AIDS-related psychopathology in subjects
without HIV-1 infection includes delusions of
having AIDS in psychotic patients, attempts to
commit suicide by contracting AIDS, and
factitious AIDS.
It is well known that psychotic patients tend
to incorporate in their delusions topics that are
of public interest at the moment. Since AIDS
has become a subject of increasing public
concern, it is not surprising that several authors
have described delusions of having contracted
AIDS in patients suffering from major de-
pression with psychotic features, schizoaffective
disorder or paranoid schizophrenia (Rapaport
& Braff, 1985; Lawlor & Stewart, 1987; O'Brien,
1987; Altamura et al. 1988; Mahorney &
Cavenar, 1988; Shetty, 1988). In these cases,
delusions resolved with adequate treatment of
the underlying disorder. AIDS delusions appear
to be more frequent in depressed patients, which
has been ascribed to the fact that the concept of
having AIDS represents an ideal delusion for a
patient whose sense of guilt seeks a tangible
form, especially if the dynamic source of guilt is
sexual indiscretion (Mahorney & Cavenar,
1988).
It is also not surprising that some subjects
have deliberately sought to be infected by AIDS
with the aim of committing suicide (Frances et
al. 1985; Flavin et al. 1986; Papathomopoulos,
1988). The risk of this behaviour has been
reported to be the highest in homosexual men
who are depressed, alcoholic and passively self-
destructive. It has been suggested that these
subjects project murderous wishes by seeking
out another as an 'executioner' (Flavin et al.
1986).
Two cases of factitious AIDS have been
reported by Miller et al. (1986). Both were
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homosexual men who presented themselves as
having AIDS but whose physical examinations
were negative. In one of them the challenge of
the diagnosis was followed by a psychotic
response, and the factitious disorder was inter-
preted as an attempt to prevent severe decom-
pensation by expressing it as a physical illness.
CONCLUDING COMMENTS
The information summarized in the present
review should be regarded as provisional, for the
following reasons: (1) many of the studies from
which it is derived appear to be weak from the
methodological viewpoint, being based on retro-
spective evaluation of small samples (or even
single cases) without or with inadequate control
groups; (2) the majority of these studies have
been carried out in Western countries and in
samples of homosexual and bisexual men, so
that the generalizability of the findings is
uncertain; (3) no large community study is at
present available, and data concerning the
prevalence of the various disorders are either
lacking or clearly conditioned by the type of
facilities where the investigation has been
conducted; (4) very few longitudinal studies
have been carried out until now, so that the
natural history of HIV-1 associated conditions
remains largely unknown; (5) the clinical charac-
terization of some HIV-1 associated disorders
is currently not precise, which hampers the
comparability of the results obtained by the
different groups (for instance, no operational
diagnostic criteria have been as yet provided for
HIV-1 dementia, and no agreement exists,
therefore, about how many and which cognitive,
behavioural and motor symptoms and signs are
required in order to diagnose this condition); (6)
the prevalence of several psychiatric disorders is
apparently higher in some groups at risk for
HIV-1 infection than in the general population,
so that assumptions concerning a causal relation-
ship between HIV-1 infection or disease and the
observed psychopathology appear sometimes to
be unwarranted.
Anyway, the evidence provided by the cur-
rently available scientific literature suggests that
the impact of HIV-1 infection on psychiatric
services is going to become dramatic worldwide.
There is clearly a need for facilities (beds for
short- and long-term care, out-patient units,
day-care centres), but especially a need for
health care professionals with adequate training
and positive attitudes towards AIDS patients.
Moreover, it is now quite evident that AIDS
care providers need support in their turn. Facing
AIDS epidemic, therefore, requires a network of
services which in some contexts will not easily
become available. On the other hand, the
challenge posed by HIV-1 infection and AIDS
may represent a favourable opportunity for the
development of community-based teams in sites
where they are not available, and for the
establishment of a closer link between psychiatry
and general medicine in contexts where the
isolation of the places where psychiatric care is
provided is still a reality.
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